Navigation Links
WeissComm Partners Promotes Diane Weiser to President and Chief Operating Officer
Date:3/25/2008

NEW YORK and SAN FRANCISCO, March 25 /PRNewswire/ -- WeissComm Partners, Inc., the fastest growing independent public relations firm in the United States, today announced the promotion of Diane Weiser to President and Chief Operating Officer. She will continue to report to WeissComm's founder and CEO, Jim Weiss, who also will become Chairman.

Since Weiser joined WeissComm in August 2004, the firm has quadrupled its revenues to $16.5 million and the number of employees to more than 75, grown its New York office, opened offices in Chicago and Washington, D.C., and established an international presence and capability.

"Diane has successfully applied more than 20 years of healthcare communications experience to WeissComm's diverse portfolio of innovative biotechnology, pharmaceutical, healthcare services, device and diagnostic clients," Weiss said. "She has taken WeissComm to a higher level with her commitment to quality and preservation of our unique independent, entrepreneurial culture, her no-nonsense, direct management style, attention to detail and thoughtful infrastructure development. In this much-deserved new role, Diane will help lead WeissComm into our next exciting phase of growth and expansion."

Prior to joining WeissComm, Weiser was director of the healthcare practice in the San Francisco office of Ketchum. In that position, she led the Genentech Avastin(R) business, managing a multi-office Best Team for the account, as well as providing counsel to other Genentech product teams. Prior to Ketchum San Francisco, Diane ran Ketchum's New York healthcare practice, which was the lead agency for the global Lipitor(R) business. She has developed and managed strategic, high-profile programs for leading pharmaceutical and biotechnology companies including Pfizer, Roche, Bayer Diagnostics, Allergan, Aventis, Celgene Corporation and Pharmacia.

About WeissComm Partners

WeissComm Partners, Inc. is a full-service public relations agency focused exclusively on serving the corporate and product communications needs of leading biotechnology, pharmaceutical, device and diagnostic companies. WeissComm's team of seasoned professionals specializes in healthcare marketing, corporate and product PR, investor and advocacy relations, clinical trial recruitment and grassroots direct-to-patient PR programs. Ranked among the top independent PR firms in the United States, WeissComm serves clients globally with offices in San Francisco, New York, Chicago, and Washington, D.C., and in London via a strategic alliance with Resolute Communications. For more information, please visit http://www.wcpglobal.com.


'/>"/>
SOURCE WeissComm Partners, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. WeissComm Partners Names Tom Jones Managing Director to Deepen Global Product Communications Offering
2. WeissComm Partners Makes 10 New Hires as It Wins New Accounts and Grows Existing Business
3. Kagome Partners With Raise the Hope to Fight Heart Disease
4. HealthMEDX Partners With Silverchair Learning Systems
5. Turner Investment Partners Added to AHA Diversified Equity Fund
6. Vista Partners Initiates Coverage on Arana Therapeutics (ASX: AAH; AIM: AAHx)
7. ACM Partners With Tufts Associated Health Plans to Improve the Cost-effective Delivery of Home Infusion Services
8. Medicine Disposal Partnership Will Encourage Public to Flush Less, Crush More
9. Country Music Star Troy Gentry Partners With National Non-Profit Patient Advocate Foundation to Spread the Message About Challenges to Healthcare Access for Insured and Uninsured Americans
10. Conseco Declines Partnerships Request for Board Seats; Review of Strategic Alternatives Underway
11. Quaker(R) Life(R) Cereal Partners with Actress and Mom Holly Robinson Peete to Inspire Moms to Make Their Best Days Happen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
Breaking Medicine Technology: